- 专利标题： 6,7,8,9-TETRAHYDRO-3H-PYRAZOLO[4,3-F]ISOQUINOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER
-
申请号： EP19189010.2申请日： 2017-10-13
-
公开(公告)号： EP3640251A1公开(公告)日： 2020-04-22
- 发明人: SCOTT, James Stewart , BARLAAM, Bernard Christophe , YANG, Bin , MOSS, Thomas Andrew , HUGHES, Samantha Jayne , NISSINK, Johannes Wilhelmus Maria , O'DONOVAN, Daniel Hillebrand
- 申请人： Astrazeneca AB
- 申请人地址： 151 85 Södertälje SE
- 专利权人： Astrazeneca AB
- 当前专利权人： Astrazeneca AB
- 当前专利权人地址： 151 85 Södertälje SE
- 代理机构： AstraZeneca
- 优先权： US201662411799P 20161024; US201662435159P 20161216
- 主分类号： C07D471/04
- IPC分类号： C07D471/04 ; A61K31/4738 ; A61K31/497 ; A61P35/00
摘要：
The specification relates to compounds of Formula (I):
and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders.
and to pharmaceutically acceptable salts thereof, to processes and intermediates used for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of cell proliferative disorders.
公开/授权文献
信息查询
